These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8894611)

  • 1. Dose-response studies with idrapril in the rat heart during acute myocardial ischaemia and reperfusion.
    Riva E; Traquandi C
    Eur J Pharmacol; 1996 Oct; 312(3):293-300. PubMed ID: 8894611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of idrapril calcium on tissue angiotensin-converting enzyme in rats.
    Becagli P; Lippi A; Criscuoli M; Breschi MC; Subissi A
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):27-32. PubMed ID: 7564361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
    Zanchi A; Nussberger J; Criscuoli M; Capone P; Brunner HR
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):317-22. PubMed ID: 7526067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new angiotensin-converting enzyme inhibitor (idrapril) in rats with left ventricular dysfunction after myocardial infarction.
    Jeremic G; Masson S; Luvara G; Porzio S; Lagrasta C; Riva E; Olivetti G; Latini R
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):347-54. PubMed ID: 8907795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans.
    Wyld PJ; Grant J; Lippi A; Criscuoli M; Del Re G; Subissi A
    Br J Clin Pharmacol; 1994 Nov; 38(5):421-5. PubMed ID: 7893583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
    Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
    Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of angiotensin I and angiotensin II: dose-response studies in the isolated perfused rat heart.
    Traquandi C; Riva E
    Pharmacol Res; 1998 Jan; 37(1):57-65. PubMed ID: 9503481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral pharmacokinetics and pharmacodynamics of idrapril calcium, the prototype of a new class of angiotensin converting enzyme inhibitors, in humans.
    Criscuoli M; Subissi A; Coppini A; Capone P; Taddei S; Salvetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S340-1. PubMed ID: 8158413
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of rabbit lung angiotensin converting enzyme by idrapril.
    Lippi A; Criscuoli M; Sardelli G; Subissi A
    Biochem Pharmacol; 1993 Mar; 45(6):1358-62. PubMed ID: 8385462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
    Takeda H; Haneda T; Kikuchi K
    Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
    Anderson B; Khaper N; Dhalla AK; Singal PK
    Can J Cardiol; 1996 Oct; 12(10):1099-104. PubMed ID: 9191504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and haemodynamic effects of idrapril calcium, the prototype of a new class of ACE-inhibitors, in essential hypertensive patients.
    Taddei S; Ghiadoni L; Mattei P; Sudano I; Duranti P; Favilla S; Virdis A; Romagnoli A; Criscuoli M; Coppini A
    Eur J Clin Pharmacol; 1995; 48(5):339-43. PubMed ID: 8641320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of cytochrome P-450 isozymes by captopril and idrapril in hepatic and renal microsomes of normotensive and spontaneously hypertensive rats.
    Moretti A; Lippi A; Criscuoli M; Subissi A; Gervasi PG
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):12-8. PubMed ID: 9268216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
    Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
    J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic oral pretreatment with the angiotensin converting enzyme inhibitor, trandolapril decreases ventricular fibrillation in acute ischaemia and reperfusion.
    Muller CA; Opie LH; Peisach M; Pineda CA
    Eur Heart J; 1994 Jul; 15(7):988-96. PubMed ID: 7925522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.
    Benter IF; Babiker F; Al-Rashdan I; Yousif M; Akhtar S
    J Diabetes Res; 2013; 2013():427693. PubMed ID: 24066305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.
    Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
    Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The myocardial protective effects of cardiac tissue ACE inhibition in experimental ischemia-reperfusion in isolated rat hearts].
    Di Napoli P; Di Gregorio G; De Sanctis F; Gallina S; Di Girolamo E; Trevi GP; Barsotti A
    Cardiologia; 1993 Feb; 38(2):107-12. PubMed ID: 8391928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.